Alkem Laboratories Limited: corporate announcements

964 records, the earliest from 24 Dec 2015. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

964 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DateCategorySubject
24 Sep 2026
07:59
Resignation of Director/KMP/SMP Alkem Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP
24 Sep 2026
07:13
Cessation Alkem Laboratories Limited has informed the Exchange regarding Change in Key Managerial Personnel Resignation of Chief Financial Officer
23 Sep 2026
08:50
Analysts/Institutional Investor Meet/Con. Call Updates Alkem Laboratories Limited has informed the Exchange about Schedule of meet
22 Sep 2026
11:56
Trading Window Alkem Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
21 Sep 2026Company Update Alkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations
21 Sep 2026
12:12
Giving guarantees/indemnity/ becoming a surety for third party Alkem Laboratories Limited has informed the Exchange issue of Corporate Guarantee
16 Sep 2026Company Update Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
16 Sep 2026
06:12
Press Release Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 16, 2026, titled "Press Release Alkem Laboratories Limited launches NeuCeno (cenobamate) for the treatment of partial-onset seizures in adult patients.".
15 Sep 2026Company Update Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management
15 Sep 2026
15:38
Appointment ALKEM: Alkem Laboratories Limited has informed the Exchange regarding Appointment of Dr. Shubhadeep Sinha as Senior Management Personnel of the company w.e.f. September 15, 2026.

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.